Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common stock, par value $0.01 per share
-
Shares outstanding
-
52,664,292
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
794,962
-
Shares change
-
+28,592
-
Total reported value, excl. options
-
$6,765,734
-
Value change
-
+$295,356
-
Number of buys
-
9
-
Number of sells
-
-5
-
Price
-
$8.51
Significant Holders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) as of Q1 2021
22 filings reported holding MBOT - Microbot Medical Inc. - Common stock, par value $0.01 per share as of Q1 2021.
Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 794,962 shares
of 52,664,292 outstanding shares and own 1.51% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (270,695 shares), BlackRock Inc. (194,352 shares), AlphaCentric Advisors LLC (100,000 shares), XXEC, Inc. (92,628 shares), GEODE CAPITAL MANAGEMENT, LLC (50,504 shares), Bank of New York Mellon Corp (18,349 shares), CITADEL ADVISORS LLC (16,493 shares), NORTHERN TRUST CORP (11,878 shares), Steward Partners Investment Advisory, LLC (11,600 shares), and MILLENNIUM MANAGEMENT LLC (11,231 shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.